Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$654.3K
23.36K shares
What this filing means
PHILLIPS ANDREW JOHN plans to sell 23.36K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $654.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000852
Director
Since Feb 2023
23.36K
Shares to sell
$654.3K
Approx. market value
21.84K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
2/2/2026
21.84KTotal acquired21.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2026 | Stock Option Exercise Cash | 21.84K | — |
| Total | 21.84K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.52K
Market value
$42.6K
1/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
21.84K
Market value
$611.7K
2/2/2026
Total
Units
23.36K
Value
$654.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/22/2026 | 1.52K | $42.6K | — | Completed |
| Planned — Approximate Date | ||||
2/2/2026 | 21.84K | $611.7K | NASDAQ | Planned |
| Total | 23.36K | $654.3K | ||